Cargando…

Gum Arabic (Acacia Senegal) Augmented Total Antioxidant Capacity and Reduced C-Reactive Protein among Haemodialysis Patients in Phase II Trial

BACKGROUND: Oxidative processes might increase in patients with end-stage renal disease (ESRD) according to the current literature. Oxidative stress (OS) is a risk factor of atherosclerosis and cardiovascular complications, which are major causes of mortality among ESRD patients. Haemodialysis (HD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Nour Elkhair, Kaddam, Lamis AbdelGadir, Alkarib, Suad Yousif, Kaballo, Babikir Gabir, Khalid, Sami Ahmed, Higawee, Abdalazim, AbdElhabib, Alaa, AlaaAldeen, Alaa, Phillips, Aled O., Saeed, Amal Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171621/
https://www.ncbi.nlm.nih.gov/pubmed/32328307
http://dx.doi.org/10.1155/2020/7214673
_version_ 1783524104407613440
author Ali, Nour Elkhair
Kaddam, Lamis AbdelGadir
Alkarib, Suad Yousif
Kaballo, Babikir Gabir
Khalid, Sami Ahmed
Higawee, Abdalazim
AbdElhabib, Alaa
AlaaAldeen, Alaa
Phillips, Aled O.
Saeed, Amal Mahmoud
author_facet Ali, Nour Elkhair
Kaddam, Lamis AbdelGadir
Alkarib, Suad Yousif
Kaballo, Babikir Gabir
Khalid, Sami Ahmed
Higawee, Abdalazim
AbdElhabib, Alaa
AlaaAldeen, Alaa
Phillips, Aled O.
Saeed, Amal Mahmoud
author_sort Ali, Nour Elkhair
collection PubMed
description BACKGROUND: Oxidative processes might increase in patients with end-stage renal disease (ESRD) according to the current literature. Oxidative stress (OS) is a risk factor of atherosclerosis and cardiovascular complications, which are major causes of mortality among ESRD patients. Haemodialysis (HD) is life-saving procedure, nevertheless it is an active chronic inflammatory status that could augment cardiovascular disease and increase mortality. Gum Arabic (GA) has been claimed to act as an antioxidant and anti-inflammatory agent in experimental studies and clinical trials. Therefore, we assumed GA supplementation among haemodialysis patients would reduce oxidative stress and consequently reduce the state of chronic inflammatory activation associated with haemodialysis. METHODS: Forty end-stage renal failure (ESRF) patients aged 18–80 years who were on regular haemodialysis in Arif Renal Center, Omdurman, Sudan, were recruited. All recruited patients met the inclusion criteria and signed informed consent prior to enrolment. The patients received 30 g/day of GA for 12 weeks. C-reactive protein (CRP) and complete blood count (CBC) were measured as baseline and monthly. Total antioxidant capacity (TAC) and oxidative stress marker malondialdehyde (MDA) levels were measured before and after GA intake. Ethical approval from the National Medicines and Poisons Board was obtained. RESULTS: Gum Arabic significantly augmented total antioxidant capacity level (P < 0.001) (95% CI, 0.408–0.625) and also attenuated oxidative marker MDA and C-reactive protein (P < 0.001). CONCLUSIONS: GA has revealed potent antioxidative and anti-inflammatory properties in haemodialysis patients. Oral digestion of GA (30 g/day) decreased oxidative stress and inflammatory markers among haemodialysis patients. Trial registration. ClinicalTrials.gov Identifier: NCT03214692, registered 11 July 2017 (prospective registration).
format Online
Article
Text
id pubmed-7171621
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71716212020-04-23 Gum Arabic (Acacia Senegal) Augmented Total Antioxidant Capacity and Reduced C-Reactive Protein among Haemodialysis Patients in Phase II Trial Ali, Nour Elkhair Kaddam, Lamis AbdelGadir Alkarib, Suad Yousif Kaballo, Babikir Gabir Khalid, Sami Ahmed Higawee, Abdalazim AbdElhabib, Alaa AlaaAldeen, Alaa Phillips, Aled O. Saeed, Amal Mahmoud Int J Nephrol Clinical Study BACKGROUND: Oxidative processes might increase in patients with end-stage renal disease (ESRD) according to the current literature. Oxidative stress (OS) is a risk factor of atherosclerosis and cardiovascular complications, which are major causes of mortality among ESRD patients. Haemodialysis (HD) is life-saving procedure, nevertheless it is an active chronic inflammatory status that could augment cardiovascular disease and increase mortality. Gum Arabic (GA) has been claimed to act as an antioxidant and anti-inflammatory agent in experimental studies and clinical trials. Therefore, we assumed GA supplementation among haemodialysis patients would reduce oxidative stress and consequently reduce the state of chronic inflammatory activation associated with haemodialysis. METHODS: Forty end-stage renal failure (ESRF) patients aged 18–80 years who were on regular haemodialysis in Arif Renal Center, Omdurman, Sudan, were recruited. All recruited patients met the inclusion criteria and signed informed consent prior to enrolment. The patients received 30 g/day of GA for 12 weeks. C-reactive protein (CRP) and complete blood count (CBC) were measured as baseline and monthly. Total antioxidant capacity (TAC) and oxidative stress marker malondialdehyde (MDA) levels were measured before and after GA intake. Ethical approval from the National Medicines and Poisons Board was obtained. RESULTS: Gum Arabic significantly augmented total antioxidant capacity level (P < 0.001) (95% CI, 0.408–0.625) and also attenuated oxidative marker MDA and C-reactive protein (P < 0.001). CONCLUSIONS: GA has revealed potent antioxidative and anti-inflammatory properties in haemodialysis patients. Oral digestion of GA (30 g/day) decreased oxidative stress and inflammatory markers among haemodialysis patients. Trial registration. ClinicalTrials.gov Identifier: NCT03214692, registered 11 July 2017 (prospective registration). Hindawi 2020-04-09 /pmc/articles/PMC7171621/ /pubmed/32328307 http://dx.doi.org/10.1155/2020/7214673 Text en Copyright © 2020 Nour Elkhair Ali et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Ali, Nour Elkhair
Kaddam, Lamis AbdelGadir
Alkarib, Suad Yousif
Kaballo, Babikir Gabir
Khalid, Sami Ahmed
Higawee, Abdalazim
AbdElhabib, Alaa
AlaaAldeen, Alaa
Phillips, Aled O.
Saeed, Amal Mahmoud
Gum Arabic (Acacia Senegal) Augmented Total Antioxidant Capacity and Reduced C-Reactive Protein among Haemodialysis Patients in Phase II Trial
title Gum Arabic (Acacia Senegal) Augmented Total Antioxidant Capacity and Reduced C-Reactive Protein among Haemodialysis Patients in Phase II Trial
title_full Gum Arabic (Acacia Senegal) Augmented Total Antioxidant Capacity and Reduced C-Reactive Protein among Haemodialysis Patients in Phase II Trial
title_fullStr Gum Arabic (Acacia Senegal) Augmented Total Antioxidant Capacity and Reduced C-Reactive Protein among Haemodialysis Patients in Phase II Trial
title_full_unstemmed Gum Arabic (Acacia Senegal) Augmented Total Antioxidant Capacity and Reduced C-Reactive Protein among Haemodialysis Patients in Phase II Trial
title_short Gum Arabic (Acacia Senegal) Augmented Total Antioxidant Capacity and Reduced C-Reactive Protein among Haemodialysis Patients in Phase II Trial
title_sort gum arabic (acacia senegal) augmented total antioxidant capacity and reduced c-reactive protein among haemodialysis patients in phase ii trial
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171621/
https://www.ncbi.nlm.nih.gov/pubmed/32328307
http://dx.doi.org/10.1155/2020/7214673
work_keys_str_mv AT alinourelkhair gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial
AT kaddamlamisabdelgadir gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial
AT alkaribsuadyousif gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial
AT kaballobabikirgabir gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial
AT khalidsamiahmed gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial
AT higaweeabdalazim gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial
AT abdelhabibalaa gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial
AT alaaaldeenalaa gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial
AT phillipsaledo gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial
AT saeedamalmahmoud gumarabicacaciasenegalaugmentedtotalantioxidantcapacityandreducedcreactiveproteinamonghaemodialysispatientsinphaseiitrial